Atlas Trials

Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias

Clinical trial NCT00472849 · COMPLETED

Trial details

NCT number
NCT00472849
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Richter's TransformationLeukemia
Start date
2007-05-01
Primary completion
2012-02-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.